ZYME Maintained by Truist Securities -- Price Target Raised to $35

gurufocus.com · 2026-10-28

Zymeworks Inc. Analyst Rating Update On October 6, 2023, Truist Securities maintained a Buy rating for Zymeworks (ZYME) while raising the price target to $35

Read the full story at gurufocus.com →